Neuropsychopharmacology
Journal of Psychopharmacology
European Neuropsychopharmacology
Psychopharmacology
- Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls6 years ago
- Differential effects of glutamate N-methyl- d -aspartate receptor antagonists on risky choice as assessed in the risky decision task6 years ago
- Effects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance6 years ago
- Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior6 years ago
- Housing conditions during self-administration determine motivation for cocaine in mice following chronic social defeat stress6 years ago
- A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania6 years ago
- The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice6 years ago
International Journal of Neuropsychopharmacology
Frontiers in Pharmacology
Translational Psychiatry
Molecular Psychiatry
Nature Reviews Neuroscience
CNS Spectrum
Neuropharmacology
Nature
- Measles makes a comeback: four charts show where and how6 months ago
- Beyond growth — why we need to agree on an alternative to GDP now6 months ago
- Nations at COP30 must cancel fossil-fuel concessions to keep the Paris agreement in reach6 months ago
- Daily briefing: This enigmatic figure reveals a common ancient myth6 months ago
- Panels of peers are needed to gauge AI’s trustworthiness — experts are not enough6 months ago
- Leaders at COP30 should promote solar and wind power over mega-dams6 months ago
- Daily briefing: This whale has been spotted alive in the wild for the first time ever6 months ago